Alteplase indications: Difference between revisions
Jump to navigation
Jump to search
Matt Pijoan (talk | contribs) m (Changed protection level for "Alteplase indications": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
(No difference)
|
Revision as of 15:55, 27 September 2011
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
- Lysis of thrombi in management of acute MI or acute massive pulmonary embolism,
- Management of acute ischemic stroke (Activase only).
- Restoration of function to central venous access device as assessed by the ability to withdraw blood (Cathflo Activase) only).
Adapted from the FDA Package Insert.